IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.18
−1.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 36.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -33.19x
- Price / sales
- 43.73x
- Price / cash flow
- -10.60x
Enterprise value
- Enterprise value
- $377.1M
- EV / sales
- 38.26x
- EV / EBITDA
- -3.59x
- EV / EBIT
- -7.45x
- Market cap
- $431.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026